Showing results (241-250 of 256) with videos related to
Sort By:
Pageof 26
AAPS Pharmscitech|August 21, 2015
Approaches to Quality Risk Management When Using Single-Use Systems in the Manufacture of BiologicsAkiko Ishii-Watabe, Akihiko Hirose, Noriko Katori, et al.JTO Clinical and Research Reports|July 4, 2025
Post-discontinuation Survival in Patients With Advanced NSCLC Receiving Immune Checkpoint Inhibitors: A Pooled Analysis of Prospective Cohort StudiesYusuke Inoue, Yoshihiro Kitahara, Masato Karayama, et al.Cancer Immunology, Immunotherapy : CII|June 6, 2021
Increased serum cholesterol and long-chain fatty acid levels are associated with the efficacy of nivolumab in patients with non-small cell lung cancerMasato Karayama, Naoki Inui, Yusuke Inoue, et al.JAMA Network Open|September 21, 2020
Evaluation of Programmed Death Ligand 1 (PD-L1) Gene Amplification and Response to Nivolumab Monotherapy in Non-small Cell Lung CancerYusuke Inoue, Katsuhiro Yoshimura, Koji Nishimoto, et al.Scientific Reports|January 23, 2026
Serum interferon-λ3 as a short-term biomarker of disease control in anti-MDA5-positive dermatomyositis-associated ILDYoshihiro Kitahara, Tomoyuki Fujisawa, Atsuki Fukada, et al.Scientific Reports|April 1, 2026
Geriatric nutritional risk index in antifibrotic therapy can predict tolerability and mortality riskTakuya Masuda, Yasutaka Mochizuka, Yuzo Suzuki, et al.Respiratory Investigation|February 1, 2025
Prevalence and clinical features of progressive pulmonary fibrosis in patients with unclassifiable idiopathic interstitial pneumonia: A post hoc analysis of prospective multicenter registryMasato Kono, Noriyuki Enomoto, Yusuke Inoue, et al.Respiratory Investigation|December 18, 2024
Association between the HAL score and the development of progressive pulmonary fibrosis in idiopathic interstitial pneumonia: A prospective observational studyHiromasa Nakayasu, Masato Karayama, Noriyuki Enomoto, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 4, 2024
Olanzapine Plus Triple Antiemetic Therapy for the Prevention of Carboplatin-Induced Nausea and Vomiting: A Randomized, Double-Blind, Placebo-Controlled Phase III TrialNaoki Inui, Takahito Suzuki, Kazuki Tanaka, et al.Arthritis & Rheumatology (Hoboken, N.J.)|December 26, 2023
Prognostic Role of Interferon-λ3 in Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis-Associated Interstitial Lung DiseaseAtsuki Fukada, Tomoyuki Fujisawa, Hironao Hozumi, et al.Pageof 26